Global Transcatheter Aortic Valve Replacement Market 2016-2020 - Development of TAVR Technology and Self-Expandable Stent Frame

Feb 03, 2016, 07:10 ET from Research and Markets

DUBLIN, Feb. 3, 2016 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Transcatheter Aortic Valve Replacement Market 2016-2020" report to their offering.

The global TAVR market to grow at a CAGR of 16.9% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global TAVR market for the period 2015-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter aortic valve implants. The report also includes a discussion of the key vendors operating in this market.

Transcatheter heart valve replacement systems are cardiovascular devices that repair the aortic valve without removing the old and damaged valves. It is used to treat aortic valve disorders such as regurgitation, aortic stenosis, and degeneration. TAVI is performed in two ways, transfemoral approach (through the femoral artery) and transapical approach (through a small chest incision).

The increasing focus on clinical trials by various vendors and research universities will lead to new product development, boosting market growth. Vendors focus on launching these newly developed products in the untapped markets such the US and APAC

According to the report, the rise in prevalence of aortic stenosis with the increase in the age to be one of the major drivers of the market. As people age, changes in the body can increase the chances of developing various diseases such as aortic stenosis. As the number of people over 60 years is expected to increase during the forecast period.

Further, the report states that the risk of potential complications associated with TAVR system restrains market growth.

Key vendors

  • Edwards Lifesciences
  • Medtronic
  • Boston Scientific
  • St. Jude Medical

Other prominent vendors

  • Direct Flow Medical
  • JenaValve Technology
  • Meril Life Sciences
  • Sorin

Key Topics Covered:

PART 01: Executive summary - Highlights

PART 02: Scope of the report

- Market overview

- Top-vendor offerings

PART 03: Market research methodology - Research methodology - Economic indicators

PART 04: Introduction

- Key market highlights

PART 05: Market landscape - Market overview - Market size and forecast - Five forces analysis

PART 06: Clinical trial studies on TAVR

PART 07: Cost analysis - Cost analysis of aortic valve replacement procedures

PART 08: Market segmentation by product

- Transfemoral implantation

- Transapical implantation

PART 09: Geographical segmentation - Global TAVR market by geography 2015-2020 - TAVR market in EMEA - TAVR market in Americas - TAVR market in APAC

PART 10: TAVR market in US

- TAVR market in the US

PART 11: Market drivers - Rise in prevalence of aortic stenosis with increase in aging population - Launch of novel transcatheter valve implants in US and Japan - Increase in adoption of MI procedures

PART 12: Impact of drivers

PART 13: Market challenges - Risk of potential complications - Threat from surgical valve implant procedures - Stringent regulations - Lack of of skilled practitioners

PART 14: Impact of drivers and challenges

PART 15: Market trends - Focus on clinical trials - Development of TAVR technology and self-expandable stent frame - Devices for a younger and lower-risk patient population

PART 16: Vendor landscape

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets